IP Library Granted Patent US 7,145,005
Granted Patent B2
US 7,145,005 · App. 10/843,917 · Granted Dec 5, 2006

2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,145,005
App. No.
10/843,917
Granted
Dec 5, 2006
Kind
B2
Abstract

The present invention relates to salts of 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one, processes for their preparation, pharmaceutical compositions comprising such compounds, method of using them, and a process for preparing the active agent.

Claims (17)

1. A method of preparing crystalline 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one citrate, comprising the steps of:

(a) dissolving 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one in a solution of citric acid and ethanol;

(b) heating the reaction mixture to a temperature of about 40° C. to about 65° C.;

(c) adding a seed slurry of 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one crystals;

(d) cooling the resulting solution to less than 5° C. for at least one hour to provide a suspension; and

(e) filtering the resulting suspension.

2. A method of preparing a 2-{6-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-naphthalen-2-yl}-2H-pyridazin-3-one, comprising the steps of:

(a) converting the trifluoro-methanesulfonic acid 6-bromo-naphthalen-2-yl ester to 2-bromo-6-vinyl-naphthalene;

(b) reacting 2-bromo-6-vinyl-naphthalene with 2-methylpyrrolidine in the presence of n-butyllithium to provide 1-[2-(6-bromo-naphthalen-2-yl)-ethyl]-2-methyl-pyrrolidine; and

(c) reacting 1-[2-(6-bromo-naphthalen-2-yl)-ethyl]-2-methyl-pyrrolidine with 2H-pyridazin-3-one.

3. The method of claim 2 , wherein the trifluoro-methanesulfonic acid 6-bromo-naphthalen-2-yl ester is obtained by:

(a) providing 6-bromo-naphthalen-2-ol; and

(b) reacting 6-bromo-naphthalen-2-ol with a suitable trifluoromethanesulfonic reagent.

4. The method of claim 1 , wherein the 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one is obtained by:

(a) converting the trifluoro-methanesulfonic acid 6-bromo-naphthalen-2-yl ester to 2-bromo-6-vinyl-naphthalene;

(b) reacting 2-bromo-6-vinyl-naphthalene with (2R)-methylpyrrolidine in the presence of n-butyllithium to provide 1-[2-(6-bromo-naphthalen-2-yl)-ethyl]-2-methyl-pyrrolidine; and

(c) reacting 1-[2-(6-bromo-naphthalen-2-yl)-ethyl]-(2R)-methyl-pyrrolidine with 2H-pyridazin-3-one.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030182/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2004
From: KU, YI-YIN; GRIEME, TIMOTHY A.; PU, YU-MING; BHATIA, ASHOK V.; TOMA, PASCAL H.; HENRY, RODGER F.; HOLLIS, LESLIE S.
To: ABBOTT LABORATORIES
Reel/Frame 015064/0563 →